跳至主要内容
临床试验/NCT04853667
NCT04853667已完成不适用

Improve Adherence to Weak or Strong Opioid Analgesics at the Time of Care in Children With Hereditary Epidermolysis Bullosa

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2021年4月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
1
主要终点
Barriers to taking weak or strong opioid analgesics prescribed

研究概览

简要总结

Hereditary epidermolysis bullosa (HEB) are rare genodermatoses, clinically characterized by epithelial and subepithelial fragility leading to the formation of blisters and spontaneous erosions on skin at the slightest contact, with possible mucosal damage.

The care of these patients consists of therapeutic baths leading to renew bandages that sometimes covering the entire integument. These are difficult, delicate and painful moments that patients experience daily at home.

For an unexplained reason for 70 to 80% of them, the weak or strong opioid analgesics, deemed necessary and prescribed for good pain control, are not taken on a regular basis as a premedication for baths and dressing changes.

The aim of the study is to understand the child's brakes on taking weak or strong opioid analgesics at the time of care and the parents' difficulties in giving these treatments by means of individual interviews.

详细描述

Hereditary epidermolysis bullosa (HEB) are rare genodermatoses, clinically characterized by epithelial and subepithelial fragility leading to the formation of blisters and spontaneous erosions on skin at the slightest contact, with possible mucosal damage.

The Pain Medicine and Palliative Medicine Functional Unit (UFMDP) of Necker Hospital is involved on a daily basis in supporting the complex and multidisciplinary management of patients with the most serious forms of hereditary epidermolysis bullosa and their family.

The care of these patients consists of therapeutic baths leading to renew bandages that sometimes covering the entire integument. These are difficult, delicate and painful moments that patients experience daily at home.

The medical and paramedical professionals, from the UFMDP and from the reference center for Genetic Diseases with Cutaneous Expression (MAGEC) (Dermatology Department) of the Necker Hospital, surrounding these children, note that for an unexplained reason for 70 to 80% of them, the weak or strong opioid analgesics, deemed necessary and prescribed for good pain control, are not taken on a regular basis as a premedication for baths and dressing changes.

Care is painful, increasing the vicious circle of anxiety, conflict with caregivers, family and ultimately pain.

研究设计

研究类型
Observational
观察模型
Family Based
时间视角
Prospective

入排标准

年龄范围
6 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Francophone children and adolescents with hereditary epidermolysis bullosa and of an age to express themselves verbally
  • •French-speaking holders of parental authority
  • •Regular follow-ups at the reference center for genetic diseases with cutaneous expression (MAGEC), dermatology department of Necker hospital
  • •Pain at the time of treatment, the evaluation of which is greater than 4/10 (visual analogue scale VAS) without taking weak or strong opioid analgesics, yet prescribed as premedication
  • •Holders of parental authority and patients informed and not opposing their participation in the study

排除标准

  • •Children and adolescents without pain at the time of treatment or for whom paracetamol is sufficient to obtain good pain control
  • •Children and adolescents already taking analgesic treatments even if their pain is not well balanced at the time of care

研究组 & 干预措施

Patients with hereditary epidermolysis bullosa

Minor patients with hereditary epidermolysis bullosa

干预措施: Interview (Other)

Parents

Parents of patients with hereditary epidermolysis bullosa

干预措施: Interview (Other)

结局指标

主要结局

Barriers to taking weak or strong opioid analgesics prescribed

时间窗: Day 0

Qualitative analysis of the semi-structured interview

次要结局

  • Barriers to giving weak or strong opioid analgesics prescribed(Day 0)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验